Helicobacter pylori infection and precancerous lesions of the stomach

Hepato-Gastroenterology

Volumn 48, Issue 42, 2001, Pages 1548-1551

  Valle, J ^a   Gisbert, J P ^a  

^a NONE   (Spain)

Author keywords

Atrophic gastritis; Dysplasia; Gastric cancer; H. pylori; Intestinal metaplasia

Indexed keywords

ASCORBIC ACID; CAROTENOID;

ATROPHIC GASTRITIS; BACTERIAL INFECTION; CANCER GROWTH; CANCER RISK; DIET; DYSPLASIA; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 0035661834     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Estimates of the worldwide frequency of eighteen major cancers in 1985
2. The decline in gastric cancer: Epidemiology of an unplanned triumph
3. The decline in the incidence of stomach cancer in Sweden 1960-1984: A birth cohort phenomenon
4. Gastric cancer and Helicobacter pylori
5. Precursors of gastric and esophageal cancer
6. Nutrition and stomach cancer
7. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China
8. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii
9. Helicobacter pylori infection and the risk of gastric carcinoma
10. Helicobacter pylori infection and chronic gastritis in gastric cancer
11. Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross-sectional data
12. Long-term sequelae of Helicobacter pylori gastritis
13. Long-term course and consequences of Helicobacter pylori gastritis: Results of a 32-year follow-up study
14. Intestinal metaplasia subtyping: Evaluation of Gomori's aldehyde fuchsin for routine diagnostic use
15. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia
16. Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers
17. bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy
18. Expression of human telomerase RNA is an early event of stomach carcinogenesis
19. A novel gastric-cancer-associated mucin antigen defined by a monoclonal antibody A3D4
20. Helicobacter pylori promotion of gastric carcinogenesis
21. Precancerous gastric lesions and Helicobacter pylori
22. Subtypes of intestinal metaplasia and Helicobacter pylori
23. Gastric epithelial dysplasia and adenoma: Historical review and histological criteria for grading
24. Gastric epithelial dysplasia in the natural history of gastric cancer: A multicenter prospective follow-up study
25. Is there a dysplasia-carcinoma sequence in rat gastric remnant?
26. Gastric dysplasia and its management
27. Value of routine, non-targeted biopsies in the diagnosis of gastric neoplasia
28. H. pylori eradication and gastric precancerous lesions
29. Clinical impact of routine biopsies of the gastric antrum and body
30. The relation of CAGA and the long-term sequelae of gastritis after successful cure of H. pylori infection: A long term follow-up study
31. Helicobacter pylori; infection and intestinal metaplasia in the stomach: Two years follow-up after eradication
32. Prospective 5-year follow-up of gastric intestinal metapla-sia following cure of H. pylori using an extensive gastric mucosal bioptic mapping protocol
33. Does eradication of H. pylori reverse gastric intestinal metaplasia? Long-term follow-up utilizing methylene blue staining
34. Genetic diversity of Helicobacter pylori
35. Geographical variations in Helicobacter pylori gastritis and gastric cancer
36. Prevalence of Helicobacter pylori in Southern Indian controls and patients with gastroduodenal disease
37. Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia
38. Determinants of Helicobacter pylori infection and chronic gastritis